IPCA Laboratories SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Ipca Laboratories

Pharmaceutical

Pharma and Healthcare

A dose of life

World leader in the anti malaria segment

Formulations, API, malaria, Nutraceutical, urology, nephrology therapeutic segment

Health care professionals in the domestic and international market

It is one of the largest pharmaceutical manufacturer & supplier

Below are the Strengths in the SWOT Analysis of IPCA Laboratories:

1. Worldwide presence in the anti- malaria segment with almost a third of share in the market

2. Company has dosage forms against all malaria disorders

3. A large network of wholesalers, sales and marketing personnel and doctors spread across the country.

4. The sales increased by a considerable amount with the company’s center of attention on the formulation segment

5. Strong and stable financial position

Here are the weaknesses in the IPCA Laboratories SWOT Analysis:

1. Intense competition means limited and slow market share growth

2. Focusing on promotional activities and brand building is less.

Following are the Opportunities in IPCA Laboratories SWOT Analysis:

1. Increasing demand for therapeutic drugs in the Indian and Chinese market is hovering on the growth in coming decades

2. The acquisition of more and more research based firms will help increase the therapeutic product range to a great extent

3. Expansion in the therapeutic segment in Nutraceutical, nephrology and urology will improve profits

The threats in the SWOT Analysis of IPCA Laboratories are as mentioned:

1. Reduced funds and infrastructure facilities for public healthcare is the cause of concern

2. Depreciating value of currency poses a threat to the research driven activities

3.Global economic slowdown

Below are the top 4 IPCA Laboratories competitors:

1. Plethico Pharma

2. Natco

3. Unichem

4. Merck